Search Orphan Drug Designations and Approvals
-
Generic Name: | cereblon E3 ubiquitin ligase modulating agent |
---|---|
Date Designated: | 08/10/2021 |
Orphan Designation: | Treatment of Multiple Myeloma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
C4 Therapeutics, Inc. 490 Arsenal Way Suite 200 Watertown, Massachusetts 02742 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-